Compare Venlon Enterpris with Similar Stocks
Dashboard
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -231.44% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of -1.00 times
Flat results in Dec 25
Risky - Negative EBITDA
Consistent Underperformance against the benchmark over the last 3 years
Stock DNA
Commodity Chemicals
INR 29 Cr (Micro Cap)
NA (Loss Making)
16
0.00%
1.76
-213.38%
4.46
Total Returns (Price + Dividend) 
Venlon Enterpris for the last several years.
Risk Adjusted Returns v/s 
Returns Beta
News

Venlon Enterprises Ltd Downgraded to Strong Sell Amid Weak Fundamentals and Bearish Technicals
Venlon Enterprises Ltd, a player in the commodity chemicals sector, has seen its investment rating downgraded from Sell to Strong Sell as of 27 February 2026. This adjustment reflects deteriorating technical indicators, weak financial trends, poor valuation metrics, and declining quality scores, signalling heightened risk for investors amid persistent operational challenges and underperformance against benchmarks.
Read full news article
Venlon Enterprises Ltd Upgraded from Strong Sell to Sell Amid Mixed Technical and Financial Signals
Venlon Enterprises Ltd, a player in the commodity chemicals sector, has seen its investment rating upgraded from Strong Sell to Sell as of 24 February 2026. This change reflects a nuanced shift in the company’s technical outlook, even as its fundamental financial performance remains subdued. The upgrade is primarily driven by improvements in technical indicators, while valuation and financial trends continue to pose challenges for investors.
Read full news article
Venlon Enterprises Q3 FY26: Losses Deepen as Revenue Plunges 57% YoY
Venlon Enterprises Ltd., a micro-cap commodity chemicals manufacturer, reported deeply concerning Q3 FY26 results that underscore the company's ongoing operational distress. The company posted a net loss of ₹0.70 crores for the quarter ended December 2025, marking a 59.09% deterioration from the ₹0.44 crores loss in Q3 FY25. More alarmingly, revenue collapsed 57.24% year-on-year to just ₹1.30 crores, whilst declining 48.82% sequentially from Q2 FY26's ₹2.54 crores. The stock, currently trading at ₹5.30 with a market capitalisation of ₹27.69 crores, gained 4.54% following the results announcement, though it remains 36.75% below its 52-week high of ₹8.38.
Read full news article Announcements 
Extra-Ordinary General Meeting Held On 13Th March 2026
17-Feb-2026 | Source : BSEWe hereby submit the notice of Extra- ordinary Genneral meeting of the Company to be held on 13th March 2026 at the registered office of the Company.
Board Meeting Outcome for Outcome Of The Board Meeting Held On 14Th February 2026
14-Feb-2026 | Source : BSEWe hereby submit the outcome of the Board meeting held today i.e. 14th February 2026 to considered the un-audited quarterly financial results of the Company along with the notes thereon and Independent Auditors Limited Review Report (Unmodified) for the quarter ended on 31st December 2025.
Results- Quarterly Financial Results For The Quarter Ended 31St Decemebr 2025
14-Feb-2026 | Source : BSEWe hereby submit the unaudited quarterly financial results of the Company along with the notes and Independent Limited Review Report (unmodified) for the quarter ended 31st March 2025.
Corporate Actions 
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 1 Schemes (0.01%)
Held by 0 FIIs
Dasu Daulatram Datwani (29.13%)
Krishna Enterprises Limited (29.43%)
9.67%
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ
QoQ Growth in quarter ended Dec 2025 is -48.82% vs 57.76% in Sep 2025
QoQ Growth in quarter ended Dec 2025 is -52.17% vs 53.54% in Sep 2025
Half Yearly Results Snapshot (Standalone) - Sep'25
Growth in half year ended Sep 2025 is -24.27% vs 28.94% in Sep 2024
Growth in half year ended Sep 2025 is -42.16% vs -155.00% in Sep 2024
Nine Monthly Results Snapshot (Standalone) - Dec'25
YoY Growth in nine months ended Dec 2025 is -36.03% vs 46.64% in Dec 2024
YoY Growth in nine months ended Dec 2025 is -47.26% vs -56.99% in Dec 2024
Annual Results Snapshot (Standalone) - Mar'25
YoY Growth in year ended Mar 2025 is 32.41% vs 265.55% in Mar 2024
YoY Growth in year ended Mar 2025 is -929.69% vs 96.14% in Mar 2024






